[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354367-105":59,"doc-detail-354367-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","17-dmag-loaded-her2-targeted-extracellular-vesicles-parpcaspase3-mediated-apoptosis-in-gastric-carcinoma","17-DMAG-Loaded HER2-Targeted Extracellular Vesicles - PARP/Caspase3-Mediated Apoptosis in Gastric Carcinoma","","Gastric cancer remains a major clinical challenge, driving demand for more effective drug delivery strategies. Approximately 10–20% of gastric tumors overexpress HER2, yet HER2-targeted treatment faces resistance and poor intratumoral antibody penetration. This study evaluates HER2-targeted exosomes delivering p51 peptide and 17-DMAG, measuring uptake and antitumor activity in vitro and in vivo. Results show enhanced HER2-specific uptake, increased PARP/caspase3-mediated apoptosis, and reduced oncogenic signaling. Systemic p51-Exo17-DMAG suppresses xenograft growth with no major-organ toxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/17-dmag-loaded-her2-targeted-extracellular-vesicles-parpcaspase3-mediated-apoptosis-in-gastric-carcinoma/354367/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/17-dmag-loaded-her2-targeted-extracellular-vesicles-parpcaspase3-mediated-apoptosis-in-gastric-carcinoma/354367.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What HER2-targeted delivery strategy does the study test?","Question",{"text":112,"@type":113},"Engineered exosomes express the p51 peptide to bind HER2 and are loaded with 17-DMAG, an HSP90 inhibitor.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is apoptosis evaluated after treatment?",{"text":117,"@type":113},"Apoptosis is assessed by increased PARP and caspase-3 cleavage and by the higher number of TUNEL-positive cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes are observed in the mouse xenograft model?",{"text":121,"@type":113},"Systemic administration of p51-Exo17-DMAG significantly inhibits tumor growth, with no toxicity or histological damage in major organs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354367,1790901258,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \n17-DMAG-Loaded HER2-Targeted Extracellular Vesicles Induce PARP/Caspase3-Mediated Apoptosis in Gastric Carcinoma  \nSin Hye Park 1, Deok Yong Sim 2, Do Sang Lee 2, Chan Mi Lee 2, Joo Won Moon 2, Ji Won Choi 2 and Dong Jin Kim 1, *  \nAcademic Editor: Hidekazu Suzuki  \nReceived: 23 April 2026  \nRevised: 11 June 2026  \nAccepted: 12 June 2026  \nPublished: 15 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Gastrointestinal Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea; [jwsh65@gmail.com](jwsh65@gmail.com)  \n2 Central Institute of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea; [simdy0821@naver.com](simdy0821@naver.com) (D.Y.S.); [dosangs@catholic.ac.kr](dosangs@catholic.ac.kr) (D.S.L.); [cksal7873@naver.com](cksal7873@naver.com) (C.M.L.); [m01410141@naver.com](m01410141@naver.com) (J.W.M.); [qrt97@naver.com](qrt97@naver.com) (J.W.C.)  \n* [Correspondence: djdjcap@catholic.ac.kr](Correspondence: djdjcap@catholic.ac.kr); Tel.: +82-02-2030-4383  \nAbstract  \nGastric cancer remains a major clinical challenge, underscoring the need for more effective drug delivery strategies. Approximately 10–20% of gastric cancers overexpress HER2, conferring aggressive tumor characteristics and poor survival, yet resistance to trastuzumabbased targeted therapy and limited intratumoral antibody penetration continue to restrict clinical outcomes. This study evaluated HER2-targeted exosomes as a delivery platform. Exosomes were engineered to express the p51 peptide, a high-affinity HER2-binding ligand, and loaded with 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a potent HSP90 inhibitor. The cellular uptake and antitumor efficacy of p51-Exo17-DMAG were assessed in vitro using NCI-N87 and AGS cells and in vivo using a mouse xenograft model. p51-modified exosomes exhibited superior HER2 specific uptake. Treatment with p51-Exo17-DMAG significantly increased apoptosis, as demonstrated by elevated PARP and caspase3 cleavage, and downregulated oncogenic signaling molecules, including p-AKT, CDK2, VEGF, and c-Myc. Furthermore, p51-Exo17-DMAG increased the number of TUNELpositive cells. In the NCI-N87 xenograft model, systemic administration of p51-Exo17-DMAG significantly inhibited tumor growth without toxicity or histological damage to major organs. Tumor analysis confirmed increased apoptosis and reduced proliferation in vivo. These findings demonstrate that p51-engineered exosomes provide an efficient, selective, and safe platform for HER2-targeted delivery of 17-DMAG, offering a promising precision medicine strategy for HER2-positive gastric cancer.  \nKeywords: gastric cancer; exosomes; HER2; 17-DMAG; apoptosis  \n1. Introduction  \nGastric carcinoma is the fifth most common malignant cancer and the fifth leading cause of cancer-related mortality worldwide [1] . Current treatment strategies include surgery, chemotherapy, immunotherapy, and targeted therapy [2,3] . For patients with unresectable advanced or metastatic gastric cancer, fluoropyrimidine-and platinum-based doublet chemotherapy has long been the standard first-line backbone; however, it yields a median overall survival of less than one year, highlighting the limited efficacy of cytotoxic regimens alone [4,5] . Recent phase 3 trials have demonstrated that the addition of PD-1 inhibitors to standard chemotherapy significantly improves progression-free and overall survival in patients with HER2-negative advanced gastric cancer [5,6] . Nevertheless, durable  \nresponses remain limited, in part due to the heterogeneous and immunosuppressive tumor microenvironment that characterizes this disease [7] . Therefore, the development of novel therapeut","cbCaicnO4izFswaJ","https://ap.wps.com/l/cbCaicnO4izFswaJ","pdf",13430373,16,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What HER2-targeted delivery strategy does the study test?\",\"answer\":\"Engineered exosomes express the p51 peptide to bind HER2 and are loaded with 17-DMAG, an HSP90 inhibitor.\"},{\"question\":\"How is apoptosis evaluated after treatment?\",\"answer\":\"Apoptosis is assessed by increased PARP and caspase-3 cleavage and by the higher number of TUNEL-positive cells.\"},{\"question\":\"What outcomes are observed in the mouse xenograft model?\",\"answer\":\"Systemic administration of p51-Exo17-DMAG significantly inhibits tumor growth, with no toxicity or histological damage in major organs.\"}]","17-DMAG-Loaded HER2-Targeted Extracellular Vesicles - PARP/Caspase3-Mediated Apoptosis in Gastric Carcinoma | PDF",1790110335,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8c034a241ed5cdd99074695243221c4.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f5ff2ddd22959338bb4be65cacc8520.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08b5d61ac92b845721f9735986a1222c.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44cb8d775aba2ea148bce7e23c431082.webp",980,1385]